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In the past few years, considerable attention has been focused on a  family of 
major histocompatibility complex (MHC)l-encoded human cell surface glycopro- 
teins, the HLA class II or Ia antigens, both because of their important role in 
the homeostasis of the immune system, and because of their possible association 
with certain diseases (reviewed in 1). 
The Ia molecules are heterodimeric structures made of noncovalently linked 
subunits of 34-36 and 24-28 kilodaitons (kD), a  and/3 chains, respectively. Both 
chains are glycosylated, and are expressed on the cell surface of a variety of cells, 
including B cells, macrophages/monocytes, and activated T  cells, as well as other 
normal tissues and tumor cells of different origin (reviewed in 2). 
From the studies of many groups (3-11),  it is now well documented that the 
human Ia antigens consist of a heterogeneous family of molecules with distinctive 
structural characteristics and various degrees of polymorphism. Molecular studies 
at the DNA level have established the existence of at least three class II subregions 
(12-15),  denominated DP,  DR, and DQ,  respectively (16).  The actual number 
of a  and/3 genes residing in each subregion is not yet established, but presently 
available  data  call  for  at  least  10-12  different functional  genes  per  haploid 
genome. The products of a  minimum of eight genes are expressed at the cell 
surface of a single B cell under the form of four distinct a-/3 heterodimers (17). 
It  is  reasonable  to  believe  that  polymorphism and  heterogeneity of the  Ia 
molecules both contribute to the various functions mediated by these molecules. 
Furthermore,  recent  data  from  several  groups  (18-24)  have  indicated  that 
modulation of class II antigen expression can occur in certain conditions, both 
in mouse and man, in various cell types, thus suggesting that the concentration 
of the  molecules  expressed  on  the  cell  surface  may constitute  an  additional 
parameter  to  be  taken  into  consideration  for  a  correct  understanding  of the 
biological functions of class II antigens. 
In  an  attempt  to  gain a  deeper  insight  into  the  mechanism controlling the 
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expression  of human  Ia  antigens,  we  have  recently (25)  generated  Ia-  B  cell 
variants,  using gamma  ray mutagenesis and immunoselection  with  monoclonal 
antibodies  (mAb)  and  complement.  Although  the  immunoselection  was  per- 
formed with monomorphic Ia-specific mAb directed against single Ia subsets, the 
resulting variants lost expression of all assessable class II antigens (25). Further 
studies (26) at the molecular level have established that the absence of expression 
of class II antigens was probably due to the inactivity of most, if not all, class II 
genes on both copies of chromosome six, since no mRNA specific for the various 
o~ and/3  subunits was found in the  Ia- variants.  Furthermore,  normal amounts 
of class  I  (HLA-A,B,C) antigens  were present  in  these variants  (25).  Another 
molecule, the In (invariant) chain glycoprotein, which is found (27-30) associated 
to the Ia ~-~ heterodimers intracellularly, was also found (26, 30) to be expressed 
in  the  Ia- variants,  although  in reduced amounts.  The  Ia- phenotype of these 
variants is highly stable, and Ia + revertant clones have not been found, to date, 
in long term cultured cells. 
By a different approach,  Gladstone and Pious (31) generated variants from a 
DR  1,3  heterozygous  B  cell  line  by  immunoselection  with  an  alloantiserum 
directed against the DR1  specificity only. Some of these variants,  like the 6.1.6 
ceils, were  lacking  both  DR1  and  DR3  specificities (31).  Both  DR1  and  DR3 
markers could be reexpressed in somatic cell hybrids between the DR- variant 
and a partner cell with different DR phenotype (32). However, the high reversion 
frequency found (33) in the 6.1.6 cell line makes it difficult to interpret  these 
results. 
By using a similar approach, we have recently (34) found that human class II 
gene expression could be restored in somatic cell hybrids between the human RJ 
2.2.5  Ia- variant and the mouse Ia  + M12.4.1  B cell lymphoma.  Based on these 
previous results,  two hypotheses have been put forward to explain  the  lack of 
expression of human class II genes in the human  RJ 2.2.5 variant:  (a), loss of a 
factor required to maintain or promote a  high concentration of specific mRNA 
either at level of synthesis or,  less likely, at the level of RNA stability; and (b), 
increased efficiency of a  mechanism  that  normally counteracts overproduction 
of mRNA,  such  as  a  super-repressor,  or  the  reactivation  of developmentally 
silent extinguisher genes. 
However,  the  fact  that  the  RJ  2.2.5  ×  M12.4.1  hybrids rapidly  segregated 
human chromosomes prevented analysis of the dominance of the RJ 2.2.5 over 
the wild-type phenotype. In essence, the suppression of the Ia- phenotype upon 
somatic cell hybridization  could either be assigned to the action of a positively- 
acting implementing factor contributed by the mouse partner, or to the loss of a 
postulated repressor-like or extinguisher function accompanying segregation of 
human chromosomes. In addition,  the RJ 2.2.5 x  M12.4.1  hybrids expressed a 
very low level of DQ antigen, if any (34); this lack of expression could be either 
attributed to some rather general property of the coexisting mouse background, 
or to a dichotomy of DR and DQ regulatory mechanisms.  This study addresses 
these questions by analyzing  interspecies hybrids generated  by fusing RJ 2.2.5 
cells with  resting  mouse  BALB/c spleen cells.  The  loss of specific phenotypic 
markers of such hybrids in culture indicated a preferential segregation of mouse ACCOLLA  ET  AL.  1119 
over human chromosomes, and made it possible to better investigate the mech- 
anism implicated in the control of class II gene expression. 
Materials and Methods 
Cells and Hybridization  Procedures.  The isolation of the human Ia- RJ 2.2.5  cell line 
has been previously described (25).  RJ 2.2.5 cells were fused with mouse spleen cells in 
the presence of polyethylene glycol (PEG) (Mr  1,000; Merck & Co., Darmstadt, Federal 
Republic of Germany) as previously described (34).  Routinely,  107  RJ 2.2.5  cells were 
mixed with  108 BALB/c spleen cells.  After fusion, cells were seeded in 24-well Costar 
plates precoated with irradiated BALB/c mouse peritoneal macrophages. 
Selective medium was added 24 h after cell fusion. Selective medium contained  10 -6 
M ouabain to select against unfused RJ 2.2.5 cells.  Human cells are much more sensitive 
than rodent cells to ouabain, a steroid-like compound that inhibits the Na/K ATPase (35). 
Preliminary experiments showed  that  the ouabain  concentration  reducing the  relative 
cloning efficiency of RJ 2.2.5 cells to 50% of that found in nonselective medium (LDs0) 
was 10 -9 M, compared to a corresponding LDs0 for rodent cells of 10  -4 M ouabain. 
Screening  and Selection of Hybrids.  Cells growing in selective medium were analyzed 
for the cell surface expression of human and murine MHC markers with the panel of 
mAb listed in Table I. The analysis was performed by indirect immunofluorescence on a 
fluorescence-activated  cell  sorter  (FACS  II;  Becton  Dickinson  Immunocytochemistry 
Systems, Mountain View, CA) as previously described (25).  For further studies, hybrids 
of interest were first sorted on the basis of positive expression of the MHC marker of 
choice (see Results) and then cloned by limiting dilution or by micromanipulation methods. 
Representative clones were chosen for detailed analysis. 
Biochemical Analysis of Cell Hybrids.  Hybrids were cell-surface labeled by the lactoper- 
oxidase-catalyzed iodination method, as previously described (30).  Detergent-solubilized 
cell extracts  were reacted with  specific mAb, and the  resulting immunoprecipitate re- 
covered by incubation with killed Staphylococcus Aureus Cowan I strain bacteria (Pansor- 
bin;  Pharmacia Fine Chemicals, Uppsala, Sweden).  In the case of the BT 3/4 antibody 
(DQ-specific),  a  Sepharose  4  B-coupled  mAb  was  used  to  purify  the  corresponding 
antigen, since this antibody does not bind to Pansorbin. 
After  elution,  the  specific immunoprecipitate  was  analyzed  by two-dimensional  gel 
electrophoresis according to O'Farrel et al. (36). 
RNA Analysis  of Cell Hybrids.  Cytoplasmic RNA was prepared as described (37) and 
dot  blotted  onto  hybridization  transfer  membranes (Gene  Screen  Plus;  New  England 
Nuclear, Boston, MA). Filters were hybridized to labeled cDNA probes in 50% formamide 
under stringent conditions, and according to the specifications of the manufacturers. The 
cDNA probes used in this study were: plasmid DR a-10, carrying a  1,170 basepair (bp) 
cDNA insert encoding the DR c~ chain (38);  plasmid DC/31, carrying a  1,140 bp cDNA 
insert encoding a  DQ 13 chain (39); p33-22, carrying a  1,100 bp cDNA insert encoding 
the p33 In chain (40). DNA labelling with a-[32p]dNTP was performed by nick translation 
according to Rigby et al. (41). 
TABLE  1 
mAb Used in This Study 
mAb  Specificity  Reference 
D1-12  Human DR  3 
BT 3/4  Human DQ1  4 
B9.12.1  Human HLA-A,B,C  43 
25.9.17  Mouse I-A  b'd p, q  44 
S13.11  Mouse H-2K  d  42 1120  REGULATION  OF  CLASS  II  GENE  EXPRESSION 
Results 
RJ 2.2.5 human  Ia- cells were fused with BALB/c spleen cells in presence of 
PEG, and cultured in ouabain-containing  medium. 
Table II shows the results obtained from a representative experiment.  When 
107 RJ 2.2.5 cells and  10  s mouse spleen cells were fused in presence of PEG, cell 
growth was observed in all wells (48 out of 48) after 2 wk of culture in selective 
medium. No cell growth was observed if PEG was omitted. Analysis of the MHC 
cell  surface  phenotype  of growing  cultures  was then  performed.  The  S13.11 
mAb specific for murine  H-2K gene products  (42) revealed that  37 out of 48 
cultures contained cells expressing the relevant antigen. The number of cells per 
culture displaying H-2K  + phenotype was 10-95%. Cultures were then analyzed 
for the presence of human  class II-specific antigens whose expression was abol- 
ished in the parental  RJ 2.2.5 cells. In the experiment reported in Table II, 36 
out of 48 cultures contained cells expressing DR-specific epitopes, as assessed by 
the Dl-12 mAb (3). The number of DR  + cells per culture was 3-75%.  Among 
these cultures,  32 were also positive for H-2K antigens,  thus leaving 5 cultures 
positive for H-2K and negative for DR markers, and 4 cultures positive for DR 
antigens but not for H-2K antigens. 
The  expression  of  human  HLA  class  I  antigens  was  also  studied  in  this 
preliminary  screening.  All 48 growing cultures,  and  100%  of the cells in each 
culture displayed HLA-A,B,C antigens, as assessed by mAb B9.12. I  (43). 
These  results  show  that  interspecies  somatic cell  fusion between human  RJ 
2.2.5  Ia-  cells and  normal  mouse  spleen  cells  generate  hybrids  in  which  the 
expression of human  Ia antigens can be restored as a  relatively frequent event, 
and  in  which  the  expression  of human  MHC  class  I  antigens  appears  to  be 
predominant with respect to its homologous murine counterpart. 
Analysis  of Human  x  Mouse Hybrids  at Population  Level.  To  investigate  in 
more detail the reexpression of human Ia antigens in RJ 2.2.5 x  BALB/c spleen 
cell hybrids, cells from a  single culture expressing the highest number of both 
H-2K  ÷ and DR  + cells were chosen for further analysis. 
Hybrid cells were selected first on the basis of H-2K  ÷ phenotype, cultured in 
vitro for a period of 14 d, and then analyzed for the presence of H-2K and DR 
antigens.  Although originally selected for H-2K, only 85% of the cells retained 
the  cell  surface  expression  of this  marker.  60%  of the  cells  were  DR  +  .  This 
TABLE  II 
RJ 2.2.5 × BALB/c Spleen Cell Hybrids Expressing Specific MHC Markers 
MHC markers  a 
Growth/wells 
Exp.*  Fusing agent  plated*  H-2K  DR  H-2K + 
DR  HLA-A,B,C 
a  PEG  48/48  37  36  32  48 
B  --  0/48  .... 
* In each experiment,  l0  T RJ  2.2.5  cells and  108  BALB/c spleen cells  were mixed together and 
treated with either PEG (A) or nothing (B). 
* Wells were screened for cell growth after three weeks in presence of selective medium (ouabain 
10 -6 M). Values indicate the total number of wells in which cell growth was observed/total number 
of wells in which the cells were plated. 
0 Total number of wells in which growing cells with the specific MHC marker were found. ACCOLLA  ET  AL.  1121 
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FIGURE  1.  Expression of human and mouse MHC markers in RJ 2.2.5 x BALB/c spleen cell 
hybrids over time. Hybrids were sorted by a FACS on the basis of H-2K  ÷ phenotype, and 
subsequently on the basis of DR* phenotype, as described in the text. At various times (abscissa) 
cell hybrids were analyzed for the presence of the specific MHC markers (0, HLA-A,B,C;  O, 
DR; A, DQ; A, H-2K; [-1, I-A) by indirect immunofluorescence and FACS; values  are expressed 
as percent positive cells (ordinate). 
population was  then sorted on the basis  of its DR  + phenotype. Analysis of the 
H-2K phenotype of the DR + cells 1 d after positive selection revealed that, again, 
~85% of such cells were H-2K  +. This finding indicates that during the initial 14- 
d  period of culture, a  subpopulation  of cells (15%  in this case) lost the murine 
class I-positive phenotype; in this subpopulation, segregation of the mouse class 
I  marker  seemed  independent  of segregation  of the  human  class  II-positive 
phenotype. 
The DR  + hybrid population was kept in culture without any further selection, 
and analyzed for the human and murine MHC cell surface phenotype every 10- 
14 d  over a period of 52 d. Fig.  1 shows the results of such analysis. 
Human class I  antigens remained constantly expressed in  100% of the popu- 
lation throughout the culture period. Conversely, at day 14 of culture, only 85% 
and 60%  of cells maintained a  DR  + and an H-2K  + phenotype, respectively. At 
this time, cells were also analyzed for reexpression of a different human class II 
marker, the DQ antigen, as well as for expression of murine I-A antigens.  78% 
of cells showed positive staining with the BT3/4 anti-DQ1  mAb (4), and 58% of 
cells were positively stained with the anti-I-A mAb 25.9.17 (44). With time, the 
hybrid cell population continued to lose cell surface expression of both human 
class II and murine class I and class I1 markers. At the end of the culture period, 
70%  and  65%  of cells were still  DR + and  DQ  + respectively, whereas  35%  and 
33% of cells retained the expression of H-2K and I-A antigens. 
From the results presented in this section, it may appear that the number of 
cells expressing human  DR antigens closely matched, over time, the number of 1122  REGULATION  OF  CLASS  II  GENE  EXPRESSION 
cells expressing  DQ  antigens,  suggesting an  overlap  of the  two  populations. 
Similar considerations could be applied to the cells expressing mouse H-2K and 
I-A antigens.  The rate of reduction in  the number of cells expressing human 
class II surface antigens paralleled a reduction in number of the cells displaying 
both class  I and class  II  murine markers.  However, throughout the period of 
culture,  the  actual  number  of cells  expressing  human  class  II  antigens  was 
consistently higher than  the corresponding number of cells expressing mouse 
MHC antigens, suggesting that reexpression of human Ia antigens t'n the hybrid 
correlated with the presence of mouse products not necessarily associated with 
the expression of murine MHC antigens. 
Analysis of  RJ 2.2.5 BALB/c Spleen Cell Hybrids at the Clonal Level.  The analysis 
of human ×  mouse hybrids was then extended to clones generated by limiting 
dilution from the same population described in the previous section at day 38 
after the DR  + selection (see Fig.  1).  12 clones were arbitrarily chosen, amplified 
in  culture,  and  characterized for  their  human  and  mouse MHC  cell  surface 
phenotype by flow microfluorometry. 
Fig.  2  summarizes the results of such analysis.  100%  of the cell population 
deriving from each clone expressed the HLA class I antigens, in agreement with 
the results obtained at population level. However, on the basis of their human 
class  II and murine class  I and II phenotypes, four groups of clones could be 
identified. Fig. 2 shows four clones, each representative of a given group; values 
represent the percentage of ceils in the cloned population displaying a specific 
MHC antigen. The first group (A) encompassed five clones, and was characterized 
by the coexpression of human class  II and mouse class  I  and II antigens in a 
comparable high number of cells. It must be stressed, however, that none of the 
clones showed expression of any one particular MHC antigen in  100%  of the 
cells. 
The  second group  of clones (group B  in  Fig.  2)  was  characterized by the 
presence of human DR and DQ antigens on a  large proportion of cells (range 
54-68%), and by a relatively much lower number of cells expressing both H-2K 
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FIGURE 2.  Expression of human and mouse MHC antigens in RJ 2.2.5 x  BALB/c spleen cell 
hybrid clones. Clones were generated by limiting-dilution methods, then analyzed by indirect 
immunofluorescence with a FACS for the presence of specific MHC markers (a, HLA-A,B,C; 
b,  DR; c,  DQ; d,  H-2K; e,  I-A). Values were expressed  in percent positive cells (ordinate). 
Four distinct reactivity patterns (A, B, C, D) were found in the clones studied. The histograms 
of four clones, each representative of a specific reactivity pattern, are shown. ACCOLLA  ET  AL.  1123 
and I-A antigens (range 4-19%). Within the limitation of the technique employed 
to count the cells positive for a given marker, the MHC phenotype of this group 
of clones clearly indicate the presence of hybrid cells, within a clone, which have 
lost expression  of mouse MHC-specific determinants  but still  retain  expression 
of human class II MHC determinants. 
The  third  group  of clones (group  C  in  Fig.  2)  included  2  clones that  were 
characterized by the virtual absence of cell surface expression of human class II 
and  mouse class  II antigens,  and  by the  presence  in  the  vast majority of cells 
(range  65-85%)  of mouse  class  I  antigens.  This  finding  contrasted  with  the 
results obtained at the population  level, where the absolute number of H-2K  + 
cells at any time in culture was (a) very similar to that of I-A cells; and (b) much 
lower than the number of human class II-positive cells. 
The  fourth  group (Fig.  2,  group D) comprised a  single clone out of the  12 
analyzed that was characterized by the virtually complete absence of cell surface 
expression of both human class II and mouse class I and class II antigens. 
We wished to determine whether the reexpression of human class II antigens 
encoded by distinct subregions like DR and DQ was quantitatively similar to that 
found in Raji cells, the B lymphoma line from which the Ia- RJ 2.2.5 variant was 
generated. 
Based on preliminary titration experiments, we chose saturating concentrations 
of the  various mAb, and  after  staining  the  cells,  we analyzed  their  MHC cell 
surface phenotype on the  FACS.  Fig.  3  shows the results obtained in  a  repre- 
sentative  clone  of group  A  (see  Fig.  2  A)  named  clone  A2-2.  As  previously 
mentioned, clear biphasic distribution of the staining was observed for anti-DR, 
anti-H-2K, and anti-I-A mAb, while the anti-human class I reagent stained 100% 
of the ceils.  The  relative amount  of fluorescence detected with these reagents 
closely paralleled that found in Raji cells (DR and HLA-class I), and in the B cell 
iymphoma line M12.4.1  (H-2K and I-A), respectively. 
In  contrast,  the  relative  fluorescence  obtained  with  the  anti-DQ1  reagent, 
BT3/4, was four- to sixfold lower in the hybrid, as compared to Raji cells (Fig. 
3, DQ). In fact, a fourfold amplification of the fluorescent signal with respect to 
the one used for Raji cells had to be used to obtain the histogram  depicted in 
Fig.  3.  Although a  clear biphasic distribution  was not appreciated,  20% of the 
A2-2  clone  hybrid  cells  were  included  in  the  area  that  overlapped  with  the 
negative control (Fig.  3, DQ/RJ, b). A  similar differential expression of DQ vs. 
DR was found in all clones of both group A and group B (data not shown) (see 
Fig. 2). 
Phenotypic Studies in Micromanipulated Hybrid Clones.  The  results presented 
in the previous section indicated that the clonal progeny of RJ2.2.5  x  BALB/c 
spleen  cell  interspecies  hybrids  expressed a  heterogenous  phenotype as far as 
MHC markers was concerned. To precisely assess whether the heterogeneity of 
expression merely reflected the preexistence of distinct hybrid clones, each one 
expressing  stable but different phenotypes,  or was due to modification  within 
the  clonal  progeny  of a  single  hybrid  species,  we  performed  the  following 
experiment.  The hybrid clone A2-2 was recioned by single-cell micromanipula- 
tion method, and among the clonal progeny, a hybrid clone was selected on the 
basis of the highest percentage of cells expressing both human class II and mouse 1124  REGULATION OF  CLASS  II  GENE  EXPRESSION 
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FIGURE 3.  Flow microfluorimetric  analysis of a  human x  mouse  cell hybrid clone  (A2-2) 
after staining with anti-class  I and anti-class  II mAb (see Table I). Each horizontal  series of 
histograms  represents  a single cell line tested  for the specific MHC marker listed on the top 
of the upper series of panels. The distinct cell lines analyzed, listed on the ordinate of the first 
left histogram of each horizontal series, were the human Raji ceils from which the Ia- RJ 2.2.5 
cells have been derived;  the RJ 2.2.5 cells (RJ); the mouse M12.4.1  BALB/c cell lymphoma 
(M12); the human x mouse hybrid clone A2-2 representative  of the group A reactivity pattern 
shown in Figure  2. Values are expressed  in arbitrary units (a.u.). Note that the histogram  of 
the  DQ-specific  fluorescence  of the  A2-2  hybrid  (b)  has  been  obtained  after  a  fourfold 
amplification of the fluorescent  signal used for the Raji cells (positive control) and the RJ 2.2.5 
cells (a, negative control).  For comparison,  in the panel of the negative control RJ 2.2.5,  the 
histogram  obtained after fourfold amplification  of the fluorescent  signal (b) has also been 
included.  For further explanations  see text. 
class  I  and  II  antigens.  This  clone,  named  A2-2.4,  displayed  the  following 
phenotype  at  the  time  of analysis:  DR,  77%;  DQ,  79%,  H-2K,  68%;  and  I-A, 
67%;  as  assessed  by  indirect  immunofluorescence  with  the  FACS  (data  not 
shown). Clone A2-2.4 was selected on the basis of an H-2K  + phenotype, and the 
day after on the  basis  of a  DR  + phenotype.  24 h  later,  the  MHC  phenotype  of 
the selected clone was reanalyzed to assess the number of cells expressing relevant 
markers,  and  it  was  found  that  100%  of cells  did  express  both  human  class  II 
(including  DR and  DQ) and  mouse  H-2K and  I-A antigens  (see  Table  III).  At 
that  time,  single  cells  were  picked  up  by micromanipulation  and  cultured.  61 
clones  deriving  from  the  A2-2.4  hybrid  clonal  population  were  then  analyzed 
for the cell surface expression  of MHC markers. 
Again,  the  only common  feature  of all  clones  consisted  in  the  expression  of 
HLA  class I antigens in  100% of the ceils (data not shown). 
On the basis of differential  expression of human class II and mouse class 1 and 
II antigens, four groups of reactivity patterns were observed (see Table III). The 
vast  majority  of clones  (41  out  of 61,  identified  as  group  A)  expressed  both 
human  and  mouse  markers  in  a  large  proportion  of cells.  In  Table  III,  the 
complete phenotype of clone c.9, a  representative  of group A, is reported.  The ACCOLLA  ET  AL. 
TABLE III 
MHC Phenotype of Micromanipulated Clones Derived  from Hybrid Clone A2-2.4 
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Total 
Group  number of  Representative 
clone  clones 
Phenotype 





--  A2-2.4  100"  100  100  100 
41  c.9  89  87  93  86 
4  c.28  71  64  24  21 
2  c.14  86  87  2  1 
4  c.29  2  1  94  1 
4  c.3  1  1  80  21* 
4  c.24  36  NT ~  91  NT 
2  c.27  1  5  5  3 
* Values are expressed in percent of positive cells detected  by indirect  immunofluorescence at the 
FACS using the mAb specific for the various MHC-markers listed in Table I. 
The relative fluorescence intensity detected with the anti-mouse I-A-specific reagent on this group 
of clones was  highly reduced  with  respect  to  the  one  found  in  the  parental  clone  A2-2.4.  For 
further explanation see the text. 
§ NT, not tested. 
phenotype of group A clones closely resembled the one observed in the parental 
A2-2.4 population. 
A  second  group  of clones,  group  B  in  Table  III,  including  six  clones,  was 
characterized by the predominant expression of human class II vs. mouse class I 
and II antigens. Among this group, four clones were identified which expressed, 
in  64-85%  of the population,  DR and  DQ antigens,  whereas only 20-25%  of 
the  populations  showed  H-2K and  I-A  markers.  The  complete phenotype  of 
clone c.28, which is representative of this  subgroup,  is presented in Table III. 
Interestingly,  the other two clones included in group  B displayed DR and  DQ 
antigens in >80% of their cells, whereas they were virtually negative for expres- 
sion of both mouse class I and class II antigens. The complete phenotype of one 
of the two clones, c. 14, is presented in the same table. 
A third group of clones, group C in Table III, including  12 hybrids, displayed 
a  peculiar phenotype characterized  by the expression of H-2K antigens and by 
the highly reduced or even absent expression of both human and mouse class II 
antigens. Within this group, four clones expressed no DR, DQ, nor I-A markers 
(representative  clone,  c.29),  and  four  clones  expressed  neither  DR  nor  DQ 
antigens, but expressed mouse I-A antigens in a variable number of cells (range 
12-35%; representative clone, c.3). It must be stressed, however, that the relative 
fluorescence intensity obtained with the anti-I-A-specific reagent was drastically 
reduced in all four clones included in this subgroup.  In fact, the mean value of 
fluorescence of the I-A  + cells detectable using FACS analysis was five- to sevenfold 
lower,  with  respect  to  the  positive control,  and  only two- to  threefold  higher 
than the negative control (data not shown). The remaining four clones included 
in group C were characterized by the presence of human class II markers (DR) 
in only 30-35% of the cells (representative clone, c.24). 1126  REGULATION  OF  CLASS  II  GENE  EXPRESSION 
A  fourth group,  called  D  in Table III,  included only 2  clones out of the 61 
analyzed. These two clones were characterized by the virtual absence of expres- 
sion  of all  human  class  II  and  mouse  class  I  and  II  antigens.  The  complete 
phenotype of one of such clone (c.27) is presented in Table III. 
In summary, the results described here closely resembled those obtained with 
clones  derived  by the  original  hybrid  population,  and  clearly  indicate  that  a 
highly homogeneous clone can give rise to heterogeneous progeny in which (a) 
concomitant segregation of mouse markers such as those of chromosome 17 can 
take place in the hybrids (groups B and D); (b) the reexpression of human class 
II antigens as well as reversion to human Ia- phenotype does not correlate with 
the expression of products of the mouse MHC (groups B and C); (c) concomitant 
loss of expression of class II antigens of both human and mouse origin can take 
place without segregation of mouse chromosome 17 (group C). 
Biochemical  Analysis  of Reexpressed  Human  Class  II Antigens.  To  assess  the 
biochemical characteristics of the human class II antigens reexpressed at the cell 
surface  of the  RJ  2.2.5  ×  BALB/c  spleen  cell  hybrids,  immunoprecipitation 
experiments  followed  by  two-dimensional  polyacrylamide  gel  electrophoresis 
(2D-PAGE) analysis were performed on cell extracts  from  125I surface-labelled 
A2-2 hybrid cells. By using mAb specific for distinct subsets of human Ia antigens 
such as DR (Fig. 4, A, C, and E) and DQ (B, D, and F), specific immunoprecipitates 
were obtained  from  A2-2 cells (Fig.  4, E  and  F) that  were very similar to the 
corresponding ones observed in Raji cells (A and B, respectively). The resulting 
Ia molecules were composed of a set of acidic spots corresponding to the a  chain 
of class II antigens,  and of a  set of more basic spots of lower molecular weight 
corresponding to the/3 chain of class II antigens.  As previously shown (30) and 
confirmed here, no specific immunoprecipitates were obtained from the Ia- RJ 
2.2.5 cells (Fig. 4, C and D, respectively). Thus, by classical biochemical criteria, 
the Ia molecules recognized by anti-DR and anti-DQ reagents in the human  × 
mouse cell hybrids did not differ from those expressed in the Raji B cells from 
which  the  Ia-  RJ  2.2.5  variant  was generated.  In  agreement  with  the  results 
obtained  by  FACS  analysis,  on  a  per  cell  basis,  the  amount  of  DQ-specific 
molecules immunoprecipitated by the BT3/4 mAb in the A2-2 hybrid (Fig. 4F) 
was significantly lower compared to that obtained in Raji cells (B). 
Studies  at  mRNA  Level.  To  finally  correlate  the  expression  of human  Ia 
antigen  in  the  human  ×  mouse  cell  hybrids  with  the  reappearance  of RNA 
transcripts,  we  prepared  total  cytoplasmic  mRNA  from  the  human  class  II- 
positive clones, A2-2 (see Fig. 3) and A2-6 (a clone with a cell surface phenotype 
equivalent to those of group B in Fig.  2), and after immobilization on nitrocel- 
lulose filters, we hybridized the mRNA with 32p-labeled cDNA probes specific 
for distinct  subunits of various  Ia subsets, as well as  with a  S2p-labeled cDNA 
probe specific for the p33 invariant  chain  molecule.  It can be seen (Fig.  5, left) 
that  the DR a-specific cDNA hybridized strongly with  the mRNA preparation 
of the  A2-2  (d)  and  A2-6  (e)  hybrid clones.  Conversely,  no hybridization  was 
observed to  mRNA preparations  from both the  RJ  2.2.5  Ia-  cells (b) and  the 
mouse M 12.4.1  B cell line (c), in agreement with our previous observations (26, 
34). 
Similarly, the cDNA probe specific for the t3 subunit of DQ antigens hybridized ACCOLLA  ET  AL.  1127 
FIGURE 4.  Two-dimensional  PAGE analysis of specific immunoprecipitates obtained from 
extracts of J2Sl cell surface-labeled Raji cells (A and B),  RJ 2.2.5 cells (C and D), and RJ 2.2.5 
x  BALB/c spleen cell hybrid clone A2-2 (E and F).  Cell extracts were immunoprecipitated 
with the DR-specific mAb Dl-12 (A, C, and E), or with the DQ-specific mAb BT 3/4 (B, D, 
and F). a  and ~3 subunits of human class II molecules are indicated in brackets. 
to mRNA preparations (Fig.  5, center)  of the A2-2 and A2-6 hybrids (Fig.  5, e 
and d, respectively), whereas no specific hybridization was observed with either 
RJ 2.2.5 (b) or M 12.4.1  (c) mRNA preparations. Although the dot blot hybridi- 
zation assay used does not allow precise assessment of the amount of specific 
mRNA detected, the results obtained with the/3-DQ probe suggest that, on a 
per cell basis,  a lower amount of specific mRNA was present in the two hybrids 
when compared to the corresponding Raji cell hybridization pattern (a).  This 
finding may help explaining why DQ molecules were reexpressed on the cell 
surface of the hybrids at a lower concentration as compared to the Raji cells (see 
Fig. 3 and 4). 
Similar experiments were then performed by using the In chain-specific cDNA 1128  REGULATION  OF  CLASS  II  GENE  EXPRESSION 
FIGURE  5.  RNA dot blot hybridizations with: (left to right) DR a-,  DQ/3-, and In chain- 
specific probes. RNA was extracted according to White and Bancroft (37) from the following 
cell lines: Raji (a);  RJ 2.2.5 (b); M12.4.1  (c); human x  mouse hybrid clone A2-2 (d); human x 
mouse hybrid clone A2-6 (e). Numbers on the left side represent serial dilution of the samples. 
107 cells were extracted in a  volume of 100 #l; 20 #l of each sample were diluted and spotted 
on to nitrocellulose filters. DR a- and In chain-specific dot blots were exposed for 2  d.  DQ 
fl-specific dot blot was exposed for 5 d. 
probe. We have previously shown (30) that In chain glycoproteins were synthe- 
sized in the  RJ 2.2.5  Ia-  variant.  This  finding correlated with the presence of 
specific mRNA in  the cytoplasm of RJ 2.2.5  cells, although  at a  reduced level 
compared to Raji cells (26). 
The  results  presented  in  Fig.  5,  right  confirm  that  In-specific  mRNA  was 
reduced in  RJ 2.2.5  cells (b) with respect to Raji cells (a).  However, when  the 
A2-2 and A2-6 hybrids were analyzed, a significant increase of specific mRNA 
was observed (e and d,  respectively), attaining  levels that  were similar  to those 
obtained in Raji cells, and suggesting that the transcription  and/or the accumu- 
lation  of this  mRNA species was enhanced  upon  RJ 2.2.5  x  mouse spleen  cell 
hybridization. 
Discussion 
Previous studies (34) of our group have shown that the Ia- phenotype of the 
B cell line RJ 2.2.5 could be suppressed at least to some extent after somatic cell 
hybridization with the mouse B lymphoma line M 12.4.1. Because of the intrinsic 
characteristics  of  the  hybrids  (preferential  segregation  of  human  vs.  mouse 
genome), it has been hard to assess whether reexpression of human Ia genes was 
regulated by a positive or negative trans-acting mechanism (see introduction and 
ref. 34). A prerequisite for such a study was, therefore, the availability of hybrids 
between  RJ  2.2.5  and  mouse  cells  capable of retaining  human  chromosomes 
while segregating the mouse counterpart.  Such hybrids were obtained by using 
BALB/c spleen  cells as fusion partners.  The  evidence  that  this  set of hybrids 
preferentially retains  human  genetic material  while losing mouse chromosomes 
resides in the fact that:  (a) markers linked to human chromosome 6 (expression 
of class I  antigens at the cell surface) were stably inherited;  (b) mouse markers 
linked to chromosome  17 (such as class I  and class II  MHC antigens) were lost 
with time in culture not only at population level (see Fig.  1), but also from clones 
derived by limiting-dilution  methods (Fig.  2, B and D), and more importantly, 
from  subclones  derived  by  micromanipulation  from  a  highly  purified  clone 
displaying a  mouse class I  and class II-positive phenotype (groups B and  D  in 
Table  III);  and  (c)  the  amount  of mouse  DNA  in  the  hybrids,  detected  by ACCOLLA ET  AL.  1129 
Southern  blotting,  decreased  with  time,  while  that  of human  DNA  remained 
constant, and paralleled a reduction in number of mouse chromosomes as assessed 
by karyotype analysis (data not shown). 
Studies at population level after selection of hybrid cells on the basis of both 
H-2K  + and DR  + phenotype revealed a progressive decrease, with time in culture, 
not only of mouse class I and class II antigen expression, but also of human class 
II expression (see Fig.  1).  If we consider the expression of human  and  mouse 
class I genes as a measure of the stability of the respective genome, we can infer 
from  Fig.  1 that  loss of human  class  II  antigen  expression  takes place  with  a 
similar rate as loss of mouse class I antigen expression. Such loss is not paralleled 
by loss of human  chromosome 6, where class II genes are located, as indicated 
by the stability of expression of human class I markers. 
Furthermore,  studies  of the  clonal progeny of highly enriched  DR  +,  mouse 
MHC-positive populations, as well as on micromanipulated clones derived from 
a  single progenitor,  clearly revealed an instability of human  class II expression 
mostly correlated with loss of expression of mouse markers. Again, even at clonal 
level, segregation of human chromosome 6 was never found. 
From these results, we can conclude that loss of human class II expression in 
the hybrids is most probably correlated with loss of mouse rather  than  human 
genetic  material.  Within  this  context,  we  consider  of importance  the  finding 
that, among the progeny of a cloned hybrid positive for the expression of class 
II antigens of both mouse and man, clones were found that lost, in a coordinate 
fashion, the expression of such antigens, still retaining the expression of murine 
class I antigens. 
As a  consequence of the above considerations,  we suggest that class II gene 
expression is regulated by a diffusible factor, acting in trans, in a positive fashion, 
irrespective of species diversity. The origin of the Ia- phenotype in RJ 2.2.5 cells 
may  thus  be  interpreted  as  a  lesion  in  a  locus  coding  for,  or  affecting  the 
expression of such a factor. 
Furthermore,  the  existence  of cloned  hybrids  having  lost  human  class  II 
expression but not mouse class I expression (Fig. 2 C and group C, Table III) or 
vice versa  (Fig.  2B and  group  B,  Table  III)  is a  good  indication  that  such  a 
regulatory gene may not be carried by the mouse chromosome  17. 
The  developmental  stages  leading  to  expression  of differentiated  functions 
can be viewed as under the control of positive gene activation processes, and/or 
controlled  by  silencing  developmental  extinguishers.  There  are  several  well- 
characterized examples of differentiated functions that become extinct because 
of the possible presence of a developmental extinguisher in cells not committed 
to the  expression  of a  differentiated  phenotype (45).  Examples of the reverse 
mechanism, that is, expression of a factor implementing gene expression only at 
appropriate  developmental  stages, are much  less  well documented.  Regulation 
of expression of class II genes may be an example of a developmental activator 
at work. 
In  a  previous  study  (34),  we  showed  that  somatic  cell  hybrids  obtained  by 
fusing RJ 2.2.5 cells with the mouse M12.4.1  B lymphoma cells expressed DR 
but not DQ antigens at the cell surface, and that this finding correlated with the 
appearance,  in the cytoplasm of the hybrid cells, of substantial amounts of DR- 1130  REGULATION  OF  CLASS  II  GENE  EXPRESSION 
specific mRNA,  and  very low amounts  (at  the  limit  of detectability) of DQ- 
specific mRNA.  In  the present  study,  we  have extended this  observation  by 
showing that mouse cells with a normal phenotype can restore the expression of 
human class II antigens upon hybridization with the Ia- RJ 2.2.5 cells. RJ 2.2.5 
×  mouse spleen cell hybrids were characterized, as a population as well as at the 
clonal level, by expression of DR and  DQ antigens, which did not differ, by 
biochemical criteria, from those expressed in Raji cells, the Ia  + human B cell line 
from which the RJ  2.2.5  variant was generated. The expression of these two 
human Ia molecular subsets correlated with the presence of the respective specific 
mRNA in the cytoplasm of the hybrids. DQ still exhibited a somewhat reduced 
expression on the cell surface of the hybrids (see Results); the reasons for such 
behavior are unclear. This event may have depended on the hybrid nature of 
the  cells,  in  which  the  residual  mouse  background  may  not  allow  the  full 
expression of both  class  II  gene families.  However, other cases are known in 
which preferential expression of human DR vs. DQ has been reported (21, 24), 
suggesting that the expression of the two class II gene clusters could be regulated 
in a different manner. 
The  finding that,  in  the  human  class  II-positive  hybrids described in  this 
study, the expression of In-specific mRNA was strongly increased indicates, as 
already suggested by analysis of RJ 2.2.5  (26),  that not only the expression of 
human  Ia  genes,  but  also  the  expression  of the  In  chain  gene  located  on 
chromosome 5 (46) is controlled directly or indirectly by the mechanism(s) altered 
in  RJ  2.2.5.  This phenomenon acquires particular importance because the In 
chain gene product is specifically associated with Ia heterodimers during biosyn- 
thesis, and has been thought (27-29) to participate to the intracellular assembly 
and/or transport of the a-/3 subunits. Based on the possible involvement of the 
In chain glycoprotein in the biosynthesis of class II antigens, it is not surprising 
that the class II genes and the In chain gene may be coordinately regulated by a 
common control mechanism, or that class II gene products may themselves affect 
In chain gene regulation. 
The presence of a seemingly sophisticated machinery determining the level of 
expression  of class  II  genes  suggests  that  gene  regulation  is  an  important 
parameter for the correct function of the immune system. 
Summary 
Raji, a human B lymphoma line, expresses high levels of major histocompati- 
bility complex (M HC) class II antigens. Conversely, none of the detectable human 
Ia antigens is present in RJ 2.2.5, an immunoselected Raji variant. Clonal analysis, 
biochemical characterization, and nucleic acid hybridization studies of hybrids 
between mouse spleen cells and RJ 2.2.5 show that MHC class II gene expression 
is regulated in trans by a factor which, as judged by dominance studies, has the 
characteristics of an activator. Such a positive trans acting factor is expressed in 
mouse spleen cells, and is able to implement MHC class II gene expression across 
species boundaries. Expression of this factor in spleen cells strongly suggests that 
it plays a role in in vivo regulation of Ia expression. Additional data suggest that 
different subsets of class II genes such as DR and DQ may, in part, be regulated 
by different mechanisms. It has also been possible to show that the amount of In ACCOLLA  ET  AL.  1131 
chain-specific mRNA,  present at  reduced  levels in  RJ  2.2.5  cells compared to 
the  parental  Raji  cells,  drastically  increased  in  human  x  mouse  cells  hybrids 
reexpressing human  Ia antigens, suggesting that the In chain gene and the class 
II genes,  although  located  on  different  chromosomes, are  regulated  in  a  con- 
certed  fashion,  either directly  through  the  same implementing  factor,  or  indi- 
rectly through a cascade mechanism. 
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